NCT06442943 Impact of the Digital Multi-domain Cognitive Intervention in High-risk Populations for Dementia
| NCT ID | NCT06442943 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fujian Provincial Hospital |
| Condition | Cognitive Dysfunction |
| Study Type | INTERVENTIONAL |
| Enrollment | 128 participants |
| Start Date | 2024-06-04 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 128 participants in total. It began in 2024-06-04 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Dementia is a chronic, progressive neurodegenerative disease characterized by acquired cognitive impairment as its core manifestation. The most common type of dementia is Alzheimer's Disease (AD), also known as "Senile Dementia," accounting for 60-80% of all dementia cases. Currently, there are approximately 10 million AD patients in China, with the number showing an increasing trend year by year, imposing a heavy economic and caregiving burden on families and society. Studies have shown that AD has a clinically silent period of 15 to 20 years (SCD\\MCI), where the risk of developing dementia is ten times higher than that of healthy elderly individuals. Nearly 50% of MCI patients progress to dementia within 5 years, and about 14.1% of SCD patients develop dementia within the same timeframe. Early detection, diagnosis, and intervention are currently the most effective strategies for preventing and treating AD. Therefore, this study aims to verify the intervention effect of integrated cognitive intervention in high-risk populations for senile dementia (SCD, MCI) based on the cognitive rehabilitation model through randomized controlled trials, and to analyze attrition rates, participation rates, etc., which have good research and application value.
Eligibility Criteria
Inclusion Criteria: * MCI (refer to Peterson's diagnostic criteria) or SCD (refer to the diagnostic framework proposed by Jak bondi and Jessen et al.); * Able to communicate normally in Mandarin; * Certain level of comprehension and judgment abilities, aware of the purpose of the survey and consents to participate. Exclusion Criteria: * Patients with dementia exhibiting abnormal mental behavior; * Individuals with severe hearing or speech impairments; * Those with serious physical illnesses who are unable to cooperate and complete the survey.
Contact & Investigator
Yuanjiao Yan, PhD
STUDY DIRECTOR
Shengli clinical medical college of Fujian Medical university
Frequently Asked Questions
Who can join the NCT06442943 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Cognitive Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06442943 currently recruiting?
Yes, NCT06442943 is actively recruiting participants. Contact the research team at fjslkyk@163.com for enrollment information.
Where is the NCT06442943 trial being conducted?
This trial is being conducted at Fuzhou, China.
Who is sponsoring the NCT06442943 clinical trial?
NCT06442943 is sponsored by Fujian Provincial Hospital. The principal investigator is Yuanjiao Yan, PhD at Shengli clinical medical college of Fujian Medical university. The trial plans to enroll 128 participants.